Allopurinol

What is it?

Composition

Each tablet contains allopurinol as the active ingredient. The usual tablet excipients may include lactose, starch, povidone, magnesium stearate, and other standard tablet-forming agents, depending on the manufacturer.

How to use?

Take Allopurinol by mouth once daily, or as directed by your prescriber. It is commonly taken after food with a full glass of water to reduce stomach upset.

Hydration matters because fluid intake supports uric acid excretion through the kidneys. This does not replace the medication, but it supports the plan.

Missed dose

If you miss a dose, take it when you remember the same day. If it is close to the next dose, skip the missed dose and return to your normal schedule. Doubling up increases side-effect risk without improving urate control.

How does it work?

Allopurinol inhibits xanthine oxidase, the enzyme that helps convert purines into uric acid. By reducing uric acid production, it lowers urate levels in the blood and urine. Over time this helps prevent urate crystal deposition in joints and kidneys.

Allopurinol is converted in the body to oxypurinol, its primary active metabolite. Oxypurinol also inhibits xanthine oxidase and contributes to the medicine’s sustained urate-lowering effect.

Indications

Allopurinol is used for gout management when blood uric acid is persistently elevated or when gout attacks recur. It is also used when high uric acid increases the risk of urate kidney stones or urate deposits (tophi).

Typical reasons clinicians choose Allopurinol include:

• Prevention of gout attacks over months to years by keeping uric acid below a target range
• Reduction of urate crystal formation in joints and soft tissues
• Lowering uric acid in urine, which can reduce the chance of urate stone formation in selected patients
• Long-term control for people who cannot manage uric acid with lifestyle measures alone

One limitation: Allopurinol does not treat an acute gout attack by itself, and starting it during a severe flare may feel worse before it feels better.

Comparison

Allopurinol is one of several ways to lower uric acid long-term. The choice depends on kidney function, prior reactions, interactions, and how far uric acid is above target.

Trade-offs are real. Xanthine oxidase inhibitors reduce uric acid “at the source,” while uricosurics push more uric acid through the kidneys and can raise stone risk in susceptible patients. Many prescribers also consider cardiovascular profile and kidney disease stage when choosing between allopurinol and febuxostat, using regulator-reviewed safety information as part of that decision. ^[4]

Contraindications

• Previous hypersensitivity reaction to allopurinol
• Concomitant use with azathioprine without prescriber-led dose adjustment
• Concomitant use with 6-mercaptopurine without prescriber-led dose adjustment
• Acute gout attack as the sole intended treatment setting
• Severe skin reaction history compatible with Stevens–Johnson syndrome or toxic epidermal necrolysis

Not recommended for

Some groups need extra care with Allopurinol, mainly because drug exposure rises when clearance is reduced.

Dose and monitoring commonly change in:

• Kidney impairment (dose may be reduced; titration is slower)
• Liver impairment (dose may be reduced and liver tests monitored)
• Older adults with multiple medicines, where interaction risk climbs

This medication is NOT for you if you have had a hypersensitivity reaction to allopurinol in the past. It is also not used as a stand-alone treatment to stop an acute gout attack.

Side effects

Most people tolerate Allopurinol well, yet side effects can happen. Skin reactions are the key safety topic with this medicine.

Common or reasonably expected effects in practice include:

• Mild rash or itching

• Nausea, diarrhoea, abdominal discomfort

• Drowsiness or dizziness in some people

• Temporary changes in liver enzymes on blood tests

• Allopurinol Hypersensitivity Syndrome (AHS): a rare, severe reaction that can include fever, widespread rash, facial swelling, liver injury, kidney injury, and blood count abnormalities.

• Severe skin reactions such as Stevens–Johnson syndrome or toxic epidermal necrolysis can start as a painful rash with blisters, mouth sores, or eye irritation.

• Rare immune-related skin findings have been reported, including allopurinol-induced vascular purpura (purple spots from small-vessel inflammation).

Stop-and-get-help symptoms are straightforward: a fast-spreading rash, blistering, fever, swollen glands, shortness of breath, yellowing of the eyes, or dark urine should be treated as urgent. WHO safety communications and drug references highlight early recognition of severe cutaneous adverse reactions as a major risk-management step for allopurinol. ^[2]

Common mistakes

People do not “fail” Allopurinol as much as they get tripped up by predictable patterns.

Mistakes that I see lead to poor control:

• Stopping after the first flare-up and assuming the medicine caused gout permanently; early flares can happen even when the long-term direction is right.
• Taking it only when symptoms appear; urate-lowering works when taken daily.
• Skipping fluids for long periods (for example during travel or long work shifts), which can worsen urate concentration in urine and trigger symptoms.
• Not mentioning azathioprine or 6-mercaptopurine to the prescriber; this interaction is high-stakes.
• Ignoring a new rash for “a few more days” instead of seeking urgent assessment.

Two practical wins: keep a simple medication list in your phone, and write down the date you started Allopurinol. It helps when a clinician asks about timing in relation to side effects.

Doctor opinions

A common clinic conversation is about targets. Doctors often document a serum urate goal (frequently <6 mg/dL in guidelines) and adjust doses until that goal is met, while checking kidney function and adverse effects. NICE guidance for gout management supports a treat-to-target approach with urate-lowering therapy where appropriate. ^[3]

One more clinical nuance: if a patient starts Allopurinol and then stops it after a flare, they tend to repeat the same cycle of flares. Consistency beats intensity here.

Frequently asked questions

How quickly does Allopurinol start lowering uric acid?

Blood uric acid can begin to fall within days of starting therapy, yet the real goal is stable control over weeks to months. Gout flares may still occur early even as uric acid drops, because existing crystal deposits are being mobilised. Treatment targets and titration are typically guided by repeat blood tests and symptoms. This approach aligns with urate-lowering therapy principles described in NICE guidance (2022).

Can Allopurinol be started during a gout flare?

Starting during a flare is a clinical decision: some clinicians start or continue urate-lowering therapy during a flare while treating the inflammation with an anti-inflammatory plan, while others wait if the flare is severe and uncontrolled. What matters is avoiding repeated start-stop cycles that destabilise urate levels. WHO drug safety resources emphasise that management plans should include flare treatment plus long-term urate control. This is best decided with a clinician who knows your history.

What is the relationship between purines, uric acid, and Allopurinol?

Purines are broken down into uric acid during normal metabolism, and uric acid rises when production is high or kidney excretion is low. Allopurinol blocks xanthine oxidase, which sits in the pathway that converts purines into uric acid. Lower uric acid means fewer urate crystals forming in joints and kidneys over time. This mechanism is described in regulator-reviewed product information used across the EU. ^[5]

Which medicines must be reviewed before starting Allopurinol?

Azathioprine and 6-mercaptopurine must be flagged because Allopurinol can increase their toxicity sharply, and prescribers adjust doses to prevent bone marrow suppression. Warfarin also deserves attention because anticoagulation may become stronger in some patients, so INR monitoring may tighten during changes. Aspirin can influence uric acid handling, so clinicians factor it into the gout plan while keeping cardiovascular indications in mind. These interaction principles are summarised in drug interaction references used in clinical practice, including FDA labeling.

Why is oxypurinol mentioned so often with Allopurinol?

Oxypurinol is the active metabolite that provides much of the sustained urate-lowering effect after dosing. Because it is cleared mainly through the kidneys, kidney function affects how long it stays in the body. This is why dosing and monitoring are more cautious in chronic kidney disease. Pharmacology references in regulator-reviewed documents describe this metabolite contribution clearly.

What precautions matter most for people with kidney or liver impairment?

Kidney impairment often requires a lower starting dose and slower titration, since both allopurinol and oxypurinol exposure can rise. Liver impairment may also need dose adjustment and periodic liver enzyme monitoring, especially if symptoms like fatigue, nausea, or dark urine appear. Drug plans often include repeat uric acid plus kidney and liver labs to balance benefit with tolerability. This risk-based approach matches urate-lowering therapy guidance used by regulators and guideline bodies.

Do you offer anonymous delivery?

Front view

Side view

Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.